(HealthDay)—COVID-19 symptom exacerbation is the leading cause of early acute-care hospital reencounters (ACHEs) after COVID-19 hospitalization, according to a study published online May 21 in GeroScience.
A Washington University study has found higher incidence of prescription opioid use among recovering COVID-19 patients, suggesting doctors are using the potent painkillers to treat the […]
Scientists at the University of York have made significant progress in the development of a nasal spray treatment for patients with Parkinson’s disease.